Display Settings:

Format

Send to:

Choose Destination
    Oman Med J. 2011 Nov;26(6):385-91.

    Gastrointestinal and Cardiovascular Risk of Nonsteroidal Anti-inflammatory Drugs.

    Source

    Section of Gastroenterology, Department of Medicine Dammam Medical Complex Hospital PO Box 18196, Al-Qatif 31911, Saudi Arabia.

    Abstract

    Nonsteroidal anti-inflammatory drugs (NSAIDs) confer a gastrointestinal (GI) side effect profile and concerns regarding adverse cardiovascular effects have emerged associated with considerable morbidity and mortality. NSAIDs are highly effective in treating pain and inflammation, but it is well recognized that these agents are associated with substantial gastrointestinal toxicity. Cyclo-oxygenase-2 inhibitors may also reduce the risk for gastrointestinal events, although they may increase cardiovascular adverse events. The selection of an appropriate analgesic or anti-inflammatory agent with or without gastroprotective therapy should be individualized.

    PMID:
    22253945
    [PubMed - in process]
    PMCID:
    PMC3251190
    Free PMC Article

      Supplemental Content

      Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk